首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Release profiles of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments prepared by different mixing methods
【24h】

Release profiles of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments prepared by different mixing methods

机译:地塞米松二丙酸酯从不同混合方法制备的类固醇和类肝素软膏混合物中的释放曲线

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Characterization and release profiles of commercial dexamethasone dipropionate (DDP) from an innovator and 2 generic ointments (Methaderm (IM), Promethasone (GP), and Mainvate (GM)) and their admixtures with heparinoid ointment (Hirudoid Soft) were investigated. The admixtures were prepared using 2 mixing methods (slab or rotation/revolution mixer). Microscopic and FT-Raman spectrometric analyses revealed that the ointments, except for IM, contained DDP crystals. A silicone membrane was used for the evaluation of the DDP permeation. The permeated DDP amounts from GP and GM were lower than that from IM, indicating that DDP solubility in the ointment vehicle affected the release of DDP from the ointment. No significant differences were observed in DDP release between IM alone and its admixture prepared using a slab; however, DDP release from the admixture prepared using a rotation/revolution mixer was significantly lower than those from IM alone and its admixture by slab. In the GP system, DDP release from the admixtures by the 2 mixing methods was higher than that from GP alone, whereas no significant difference in DDP release between the 2 mixing methods was observed. No significant differences were observed between the GM and admixtures. The apparent solubility of DDP in the admixtures as determined by the ultracentrifugal separation method indicated that the DDP amount in the liquid phase of admixtures with GP was 6 times higher than that of admixtures with IM or GM. Therefore, the apparent solubility of DDP in the liquid phase in the GP system might influence the DDP release in admixtures.
机译:研究了来自创新者和2种通用软膏(Methaderm(IM),Promethasone(GP)和Mainvate(GM))及其与肝素软膏(Hirudoid Soft)的混合物的商业化地塞米松二丙酸酯(DDP)的表征和释放曲线。使用两种混合方法(平板或旋转/旋转混合器)制备混合物。显微镜和FT-拉曼光谱分析表明,除IM之外,该药膏均含有DDP晶体。将硅树脂膜用于DDP渗透性的评估。 GP和GM的DDP渗透量低于IM的渗透量,表明DDP在软膏载体中的溶解度影响DDP从软膏中的释放。单独的IM和使用平板制备的混合物之间的DDP释放没有观察到显着差异。但是,使用旋转/旋转混合器制备的混合物中的DDP释放量显着低于仅使用IM及其通过平板进行的混合物中的DDP释放。在GP系统中,通过两种混合方法从混合物中释放的DDP高于单独从GP中释放的DDP,而在两种混合方法之间未观察到DDP释放的显着差异。 GM和混合物之间没有观察到显着差异。通过超速离心分离法测定的DDP在混合物中的表观溶解度表明,与GP的混合物在液相中的DDP量比与IM或GM的混合物高6倍。因此,GP系统中液相中DDP的表观溶解度可能会影响DDP在混合物中的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号